Lalani, A.-K. A. (2017) “First-line sunitinib or pazopanib in metastatic renal cell carcinoma: The Canadian experience”, Canadian Urological Association Journal, 11(3-4), pp. 112–7. doi: 10.5489/cuaj.4398.